Ascent Capital Group, Inc. (NASDAQ:ASCMA)
Ascent Capital Group, Inc. (NASDAQ:ASCMA) represented a move of 0 percent or $0 per share and closed its previous day trading session at $0.85. 0 Shares were traded in the last trading session with an Average Volume of 365.17 Million Shares. The stock currently has a Market Capitalization of 10.56 Million.
Ascent Capital Group, Inc. is a holding company and its assets primarily consist of its wholly-owned subsidiary, Monitronics International, Inc. The Company provides security alarm monitoring and related services to residential and business subscribers throughout the United States and parts of Canada. Monitronics monitors signals arising from burglaries, fires and other events through security systems at subscribers’ premises. Ascent Capital Group, Inc., formerly known as Ascent Media Corporation, is based in Englewood, Colorado.
The stock traded between $ 0.760 and $12.790 over 1-Year time period showing its price to sales ratio of 0.02. Ascent Capital Group, Inc. (NASDAQ:ASCMA) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-29.17 and 200-Day Simple Moving Average of $-68.18. Its Price to Free Cash Flow is 0.14 and Price to Book of 0.
Analyst’s recommended the stock as 2.5 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Ascent Capital Group, Inc. (NASDAQ:ASCMA) reported its Actual EPS of $-2.7/share. The analysts offering Earnings Estimates for the company were believing that Ascent Capital Group, Inc. could bring EPS of $-2.52/share. The difference between Actual EPS and Estimated EPS was -0.18 Percent. Thus showing an Earnings Surprise of -7.1 Percent.
Ovid Therapeutics Inc. (NASDAQ:OVID)
In the last trading session, Ovid Therapeutics Inc. (NASDAQ:OVID) added its value by 0% closing at the price of $3.49. The stock currently has market capitalization of 85.82 Million, with average volume of 82.31 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Ovid Therapeutics Inc. (NASDAQ:OVID) is showing beta of 0. This particular value of beta suggests that Ovid Therapeutics Inc. (NASDAQ:OVID) has historically moved 0% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Ovid Therapeutics Inc. (NASDAQ:OVID) is at $-1.64.
The stock currently has RSI of 30.05. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Ovid Therapeutics Inc. is a biopharmaceutical company. It engaged in developing therapies for patients with rare neurological disorders. The company’s product pipeline consists of OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. It also involved in developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid Therapeutics Inc. is based in New York, United States.
Ovid Therapeutics Inc. (NASDAQ:OVID) topped its 52-week high price of $12.19 on 12/11/17 and 52-Week Low Price of $ 3.22 on 12/04/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 13.62% and monthly volatility of 11.41% respectively.